Radiopharm Theranostics RADX
NASDAQ RADX
$0.88 -0.07 (-7.70%)
At close: Nov 9, 2026 · 4:00 PM EST

Radiopharm Theranostics (RADX) Total Debt (2024 - 2026)

Updated

Radiopharm Theranostics' Total Debt came in at $182,827 for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 11.1% from $205,568 a year earlier.

Analysis

Radiopharm Theranostics (RADX) Total Debt (2024 - 2026) Analysis & Trends

At the end of FY2026 (ended Jun 30, 2026), Radiopharm Theranostics' Total Debt was $175,045, down 99.5% from FY2025.

  • Going back by fiscal year, Total Debt was $32.1 million in FY2025 and $220,289 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 49.50 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 44.65 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 80.90 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 53.78 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -11.96 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 54.01 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 26.23 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 62.67 Bn
10 Radiopharm Theranostics 2.70 Bn 2.62 Bn - 6.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.86 Mn
Jun 30, 2025 3.42 Mn
Dec 31, 2024 2.24 Mn
Jun 30, 2024 6.32 Mn
API Access

Radiopharm Theranostics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=RADX&period=max&api_key=YOUR_API_KEY